Alexion Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Alexion Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 22% to $6,069,900,000. Profit margin reached 10%. Total operating expenses were $2,656,500,000.
Profit Margin
| 2011 | 783.43M | 175.31M | 22.38% |
|---|---|---|---|
| 2012 | 1.13B | 254.82M | 22.47% |
| 2013 | 1.55B | 252.89M | 16.3% |
| 2014 | 2.23B | 656.91M | 29.41% |
| 2015 | 2.60B | 144.38M | 5.54% |
| 2016 | 3.08B | 399M | 12.94% |
| 2017 | 3.55B | 443.3M | 12.48% |
| 2018 | 4.13B | 77.6M | 1.88% |
| 2019 | 4.99B | 2.40B | 48.17% |
| 2020 | 6.06B | 603.4M | 9.94% |
ALXN Income Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 6.06B | 4.99B | 4.13B | 3.55B | 3.08B | 2.60B | 2.23B | 1.55B | 1.13B | 783.43M |
Cost of revenue | 553.5M | 394.5M | 374.3M | 454.2M | 258M | 233.08M | 173.86M | 177.55M | 72.83M | 93.14M |
Gross profit | 5.51B | 4.59B | 3.75B | 3.09B | 2.82B | 2.37B | 2.05B | 1.37B | 1.06B | 690.29M |
Operating exp. | ||||||||||
Research and development | 1.00B | 886M | 730.4M | 878.4M | 757M | 709.47M | 513.78M | 317.09M | 222.73M | 137.42M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 2.65B | 2.45B | 2.16B | 2.29B | 2.03B | 1.68B | 1.14B | 807.23M | 607.82M | 445.97M |
Operating income | 2.85B | 2.13B | 1.59B | 804M | 793M | 682.30M | 915.88M | 566.56M | 453.45M | 244.31M |
Other income (expenses), net | -2.29B | 38.9M | -1.35B | -256.2M | -217M | -184.16M | -43.77M | -40.29M | -55.88M | 14.64M |
Income before tax | 569M | 2.17B | 242.2M | 547.8M | 576M | 498.14M | 872.10M | 526.26M | 397.56M | 229.66M |
Income tax expense | -34.4M | -225.5M | 164.6M | 104.5M | 177M | 353.75M | 215.19M | 273.37M | 142.74M | 54.35M |
Net income | 603.4M | 2.40B | 77.6M | 443.3M | 399M | 144.38M | 656.91M | 252.89M | 254.82M | 175.31M |
Earnings per share | ||||||||||
Basic EPS | 2.75 | 10.7 | 0.35 | 1.98 | 1.78 | 0.68 | 3.32 | 1.29 | 1.34 | 0.96 |
Diluted EPS | 2.75 | 10.7 | 0.35 | 1.97 | 1.76 | 0.67 | 3.26 | 1.27 | 1.28 | 0.91 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |